207 related articles for article (PubMed ID: 33067920)
61. Mannose-binding lectin gene polymorphism associated with the patterns of glomerular immune deposition in IgA nephropathy.
Gong R; Liu Z; Li L
Scand J Urol Nephrol; 2001 Jun; 35(3):228-32. PubMed ID: 11487077
[TBL] [Abstract][Full Text] [Related]
62. Gluten sensitivity in patients with IgA nephropathy.
Smerud HK; Fellström B; Hällgren R; Osagie S; Venge P; Kristjánsson G
Nephrol Dial Transplant; 2009 Aug; 24(8):2476-81. PubMed ID: 19332868
[TBL] [Abstract][Full Text] [Related]
63. Pathogenesis of IgA nephropathy.
Feehally J; Allen AC
Ann Med Interne (Paris); 1999 Feb; 150(2):91-8. PubMed ID: 10392257
[TBL] [Abstract][Full Text] [Related]
64. Regulation of IgA Class Switch Recombination in Immunoglobulin A Nephropathy: Retinoic Acid Signaling and BATF.
He L; Peng X; Chen Y; Liu G; Liu Z; Zhu J; Liu Y; Liu H; Liang Y; Liu F; Sun L; Peng Y
Am J Nephrol; 2016; 43(3):179-94. PubMed ID: 27073891
[TBL] [Abstract][Full Text] [Related]
65. Altered production of IgE and IgA induced by IL-4 in peripheral blood mononuclear cells from patients with IgA nephropathy.
Yano N; Endoh M; Miyazaki M; Yamauchi F; Nomoto Y; Sakai H
Clin Exp Immunol; 1992 May; 88(2):295-300. PubMed ID: 1572094
[TBL] [Abstract][Full Text] [Related]
66. Low levels of spontaneously activated peripheral IgA-secreting cells in nontransplanted IgA nephropathy patients.
Kennel-De March A; Béné MC; Renoult E; Kessler M; Faure GC
Am J Kidney Dis; 1997 Jul; 30(1):64-70. PubMed ID: 9214403
[TBL] [Abstract][Full Text] [Related]
67. The role of complement in IgA nephropathy.
Tortajada A; Gutierrez E; Pickering MC; Praga Terente M; Medjeral-Thomas N
Mol Immunol; 2019 Oct; 114():123-132. PubMed ID: 31351413
[TBL] [Abstract][Full Text] [Related]
68. Application of circular consensus sequencing and network analysis to characterize the bovine IgG repertoire.
Larsen PA; Smith TP
BMC Immunol; 2012 Sep; 13():52. PubMed ID: 22978666
[TBL] [Abstract][Full Text] [Related]
69. IgA-containing immune complexes after challenge with food antigens in patients with IgA nephropathy.
Jackson S; Moldoveanu Z; Kirk KA; Julian BA; Patterson TF; Mullins AL; Jilling T; Mestecky J; Galla JH
Clin Exp Immunol; 1992 Aug; 89(2):315-20. PubMed ID: 1638775
[TBL] [Abstract][Full Text] [Related]
70. Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen. Dependence on antigen form and immune status.
Jessen RH; Emancipator SN; Jacobs GH; Nedrud JG
Lab Invest; 1992 Sep; 67(3):379-86. PubMed ID: 1328763
[TBL] [Abstract][Full Text] [Related]
71. Immunopathological features of palatine tonsil characteristic of IgA nephropathy: IgA1 localization in follicular dendritic cells.
Kusakari C; Nose M; Takasaka T; Yuasa R; Kato M; Miyazono K; Fujita T; Kyogoku M
Clin Exp Immunol; 1994 Jan; 95(1):42-8. PubMed ID: 7507015
[TBL] [Abstract][Full Text] [Related]
72. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
Jiang L; Zhang JJ; Lv JC; Liu G; Zou WZ; Zhao MH; Zhang H
Nephrol Dial Transplant; 2008 Dec; 23(12):3921-7. PubMed ID: 18603547
[TBL] [Abstract][Full Text] [Related]
73. Next-generation sequencing analysis of the human T-cell and B-cell receptor repertoire diversity before and after hepatitis B vaccination.
Miyasaka A; Yoshida Y; Wang T; Takikawa Y
Hum Vaccin Immunother; 2019; 15(11):2738-2753. PubMed ID: 30945971
[TBL] [Abstract][Full Text] [Related]
74. Mapping novel immunogenic epitopes in IgA nephropathy.
Woo SH; Sigdel TK; Dinh VT; Vu MT; Sarwal MM; Lafayette RA
Clin J Am Soc Nephrol; 2015 Mar; 10(3):372-81. PubMed ID: 25542908
[TBL] [Abstract][Full Text] [Related]
75. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
Nakazawa S; Imamura R; Kawamura M; Kato T; Abe T; Namba T; Iwatani H; Yamanaka K; Uemura M; Kishikawa H; Nishimura K; Oka K; Tajiri M; Wada Y; Nonomura N
Biochem Biophys Res Commun; 2019 Jan; 508(4):1106-1112. PubMed ID: 30553446
[TBL] [Abstract][Full Text] [Related]
76. Cytokine-induced immunoglobulin production in primary IgA nephropathy.
van den Wall Bake AW; Crowley-Nowick PA; Kulhavy R; Hermans J; Jackson S; Julian BA; Mestecky J
Am J Kidney Dis; 1992 Dec; 20(6):611-7. PubMed ID: 1462991
[TBL] [Abstract][Full Text] [Related]
77. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
Ebefors K; Liu P; Lassén E; Elvin J; Candemark E; Levan K; Haraldsson B; Nyström J
BMC Nephrol; 2016 Apr; 17():40. PubMed ID: 27044423
[TBL] [Abstract][Full Text] [Related]
78. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
[TBL] [Abstract][Full Text] [Related]
79. Decreased IgA1 response after primary oral immunization with live typhoid vaccine in primary IgA nephropathy.
Roodnat JI; de Fijter JW; van Kooten C; Daha MR; van Es LA
Nephrol Dial Transplant; 1999 Feb; 14(2):353-9. PubMed ID: 10069188
[TBL] [Abstract][Full Text] [Related]
80. IgA synthesis by lymphocytes from patients with IgA nephropathy and their relatives.
Waldo FB; Beischel L; West CD
Kidney Int; 1986 Jun; 29(6):1229-33. PubMed ID: 3747336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
